Difference between revisions of "Fluvoxamine-maprotiline"
From Psychiatrienet
(Created page with '{{Drugswitch | from = fluvoxamine | to = maprotiline | stop = * '''Day 0:''' gradually reduce dosage of fluvoxamine to a maximum of 50 mg/ day when this dosage is > 50 mg/day....') |
|||
| Line 10: | Line 10: | ||
* '''Day 8:''' stop administration of fluvoxamine and continue administration of maprotiline. If necessary, increase dosage of maprotiline. | * '''Day 8:''' stop administration of fluvoxamine and continue administration of maprotiline. If necessary, increase dosage of maprotiline. | ||
| info = | | info = | ||
| − | * Fluvoxamine slows the metabolism of | + | * Fluvoxamine slows the metabolism of maprotiline via CYP1A2 and CYP2D6. |
* "Start low, go slow" is not required, but caution is necessary.}} | * "Start low, go slow" is not required, but caution is necessary.}} | ||
Revision as of 20:16, 3 May 2009
| ||||||||||||||||||||||
| ||||||||||||||||||||||
Switch medication from fluvoxamine to maprotiline.[1] [2]
Stop fluvoxamine - Day 0: gradually reduce dosage of fluvoxamine to a maximum of 50 mg/ day when this dosage is > 50 mg/day.
- Day 1: reduce dosage of fluvoxamine to a maximum of 25 mg/day.
Start maprotilineCaution is necessary.
- Day 1: simultaneously start administration of maprotiline in a low dosage of 25-75 mg/day.
- Day 8: stop administration of fluvoxamine and continue administration of maprotiline. If necessary, increase dosage of maprotiline.
More information- Fluvoxamine slows the metabolism of maprotiline via CYP1A2 and CYP2D6.
- "Start low, go slow" is not required, but caution is necessary.
- ↑ Switches are based on literature references on this page and expert opinions of the authors. The authors have used pharmacokinetic and receptor affinity properties to determine the switch schedules
- ↑ Stahl, S. M. (2013). Stahl's essential psychopharmacology: Neuroscientific basis and practical applications (4th ed.). Cambridge University Press.
The editors of psychiatrienet.nl take the greatest care to provide up-to-date and accurate information on this site. Nevertheless, mistakes and omissions cannot be entirely excluded. No rights devolve from the information provided. The editors and other providers of information to this site accept no responsibility for the content of this site or for the information provided therein; neither do they accept responsibility for possible damages which may derive from the use of the information on this site or from the linked sites. The editorial board accepts no responsibility for the content of the (linked) sites, for access to them, or for the products and services on these sites, nor for the occurrence of errors, viruses, and/or disruptions in service.
